INBS — Intelligent Bio Solutions Balance Sheet
0.000.00%
- $9.35m
- $8.34m
- $3.05m
- 28
- 22
- 27
- 14
Annual balance sheet for Intelligent Bio Solutions, fiscal year end - June 30th, USD millions except per share, conversion factor applied.
2021 June 30th | 2022 June 30th | 2023 June 30th | 2024 June 30th | 2025 June 30th | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Short Term Investments | 12.6 | 8.24 | 1.54 | 6.3 | 1.02 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 3.21 | 2.47 | 0.833 | 0.978 | 1.6 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 18.2 | 10.9 | 3.86 | 8.53 | 4.14 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | — | 0.391 | 1.24 | 0.873 | 0.321 |
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 21.9 | 12.4 | 10.4 | 13.8 | 8.25 |
| Accounts Payable | |||||
| Payable / Accrued | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 3.68 | 4.66 | 5.88 | 5.45 | 5.35 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 6.8 | 5.73 | 6.56 | 5.45 | 5.25 |
| Redeemable Preferred Stock | |||||
| Non Redeemable Preferred Stock | |||||
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Other Equity | |||||
| Total Equity | 15.1 | 6.62 | 3.8 | 8.33 | 3 |
| Total Liabilities & Shareholders' Equity | 21.9 | 12.4 | 10.4 | 13.8 | 8.25 |
| Total Common Shares Outstanding | |||||
| Total Preferred Shares Outstanding |